These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24816171)

  • 81. An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8(+) T cells and antibody when expressed from modified vaccinia Ankara.
    Quinan BR; Flesch IE; Pinho TM; Coelho FM; Tscharke DC; da Fonseca FG
    Vaccine; 2014 May; 32(25):2972-9. PubMed ID: 24726244
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Recognition of synthetic oligopeptides from nonstructural proteins NS1 and NS3 of dengue-4 virus by sera from dengue virus-infected children.
    Garcia G; Vaughn DW; Del Angel RM
    Am J Trop Med Hyg; 1997 Apr; 56(4):466-70. PubMed ID: 9158059
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine.
    Lin TH; Chen HW; Hsiao YJ; Yan JY; Chiang CY; Chen MY; Hu HM; Wu SH; Pan CH
    Front Immunol; 2020; 11():546. PubMed ID: 32300346
    [TBL] [Abstract][Full Text] [Related]  

  • 84. High affinity human antibody fragments to dengue virus non-structural protein 3.
    Moreland NJ; Tay MY; Lim E; Paradkar PN; Doan DN; Yau YH; Geifman Shochat S; Vasudevan SG
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e881. PubMed ID: 21085466
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A protective role for dengue virus-specific CD8+ T cells.
    Yauch LE; Zellweger RM; Kotturi MF; Qutubuddin A; Sidney J; Peters B; Prestwood TR; Sette A; Shresta S
    J Immunol; 2009 Apr; 182(8):4865-73. PubMed ID: 19342665
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes.
    Bashyam HS; Green S; Rothman AL
    J Immunol; 2006 Mar; 176(5):2817-24. PubMed ID: 16493038
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cross-reactive Dengue virus-specific CD8
    Regla-Nava JA; Elong Ngono A; Viramontes KM; Huynh AT; Wang YT; Nguyen AT; Salgado R; Mamidi A; Kim K; Diamond MS; Shresta S
    Nat Commun; 2018 Aug; 9(1):3042. PubMed ID: 30072692
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection.
    Wan SW; Chen PW; Chen CY; Lai YC; Chu YT; Hung CY; Lee H; Wu HF; Chuang YC; Lin J; Chang CP; Wang S; Liu CC; Ho TS; Lin CF; Lee CK; Wu-Hsieh BA; Anderson R; Yeh TM; Lin YS
    J Immunol; 2017 Oct; 199(8):2834-2844. PubMed ID: 28904127
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cultured ELISpot Assay to Investigate Dengue Virus Specific T-Cell Responses.
    Jeewandara C; Ogg GS; Malavige GN
    Methods Mol Biol; 2018; 1808():165-171. PubMed ID: 29956182
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
    Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
    Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Epitope reactions can be gauged by relative antibody discriminating specificity (RADS) values supported by deletion, substitution and cysteine bridge formation analyses: potential uses in pathogenesis studies.
    Falconar AK
    BMC Res Notes; 2012 Jul; 5():208. PubMed ID: 22546090
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions.
    Chakraborty S; Chakravorty R; Ahmed M; Rahman A; Waise TM; Hassan F; Rahman M; Shamsuzzaman S
    In Silico Biol; 2010; 10(5-6):235-46. PubMed ID: 22430357
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cross-reactive antibodies targeting surface-exposed non-structural protein 1 (NS1) of dengue virus-infected cells recognize epitopes on the spaghetti loop of the β-ladder domain.
    Kraivong R; Traewachiwiphak S; Nilchan N; Tangthawornchaikul N; Pornmun N; Poraha R; Sriruksa K; Limpitikul W; Avirutnan P; Malasit P; Puttikhunt C
    PLoS One; 2022; 17(5):e0266136. PubMed ID: 35617160
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
    Grifoni A; Moore E; Voic H; Sidney J; Phillips E; Jadi R; Mallal S; De Silva AD; De Silva AM; Peters B; Weiskopf D; Sette A
    Front Immunol; 2019; 10():1568. PubMed ID: 31333679
    [No Abstract]   [Full Text] [Related]  

  • 95. A systematic bioinformatics approach for selection of epitope-based vaccine targets.
    Khan AM; Miotto O; Heiny AT; Salmon J; Srinivasan KN; Nascimento EJ; Marques ET; Brusic V; Tan TW; August JT
    Cell Immunol; 2006 Dec; 244(2):141-7. PubMed ID: 17434154
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates.
    Chawla YM; Bajpai P; Saini K; Reddy ES; Patel AK; Murali-Krishna K; Chandele A
    Viruses; 2024 May; 16(5):. PubMed ID: 38793612
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Sculpting the immunological response to dengue fever by polytopic vaccination.
    Zhou H; Deem MW
    Vaccine; 2006 Mar; 24(14):2451-9. PubMed ID: 16417956
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone.
    Moran E; Simmons C; Chau NV; Luhn K; Wills B; Phuong Dung N; Thao LTT; Hien TT; Farrar J; Rowland-Jones S; Dong T
    Eur J Immunol; 2008 Apr; 38(4):1050-1057. PubMed ID: 18383038
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.
    Weiskopf D; Angelo MA; Bangs DJ; Sidney J; Paul S; Peters B; de Silva AD; Lindow JC; Diehl SA; Whitehead S; Durbin A; Kirkpatrick B; Sette A
    J Virol; 2015 Jan; 89(1):120-8. PubMed ID: 25320311
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets.
    Weiskopf D; Cerpas C; Angelo MA; Bangs DJ; Sidney J; Paul S; Peters B; Sanches FP; Silvera CG; Costa PR; Kallas EG; Gresh L; de Silva AD; Balmaseda A; Harris E; Sette A
    J Infect Dis; 2015 Dec; 212(11):1743-51. PubMed ID: 25980035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.